Transactivation of the Moloney murine leukemia virus and T-cell receptor beta-chain enhancers by cbf and ets requires intact binding sites for both proteins.
about
Functional and physical interactions between AML1 proteins and an ETS protein, MEF: implications for the pathogenesis of t(8;21)-positive leukemiasA novel transcript encoding an N-terminally truncated AML1/PEBP2 alphaB protein interferes with transactivation and blocks granulocytic differentiation of 32Dcl3 myeloid cellsCellular transcription factor ZASC1 regulates murine leukemia virus transcriptionTranscriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressorsCloning of the novel human myeloid-cell-specific C/EBP-epsilon transcription factorALY is a common coactivator of RUNX1 and c-Myb on the type B leukemogenic virus enhancerRegulation of the human LAT gene by the Elf-1 transcription factorStructural basis of Ets1 cooperative binding to palindromic sequences on stromelysin-1 promoter DNAStructural Basis of Ets1 Cooperative Binding to Widely Separated Sites on Promoter DNAStructural basis of Ets1 activation by Runx1DNA specificity determinants associate with distinct transcription factor functionsTandemization of a subregion of the enhancer sequences from SRS 19-6 murine leukemia virus associated with T-lymphoid but not other leukemias.Multiple functional domains of AML1: PU.1 and C/EBPalpha synergize with different regions of AML1The leukemic protein core binding factor beta (CBFbeta)-smooth-muscle myosin heavy chain sequesters CBFalpha2 into cytoskeletal filaments and aggregatesMembers of the GATA family of transcription factors bind to the U3 region of Cas-Br-E and graffi retroviruses and transactivate their expression.Increased induction of osteopetrosis, but unaltered lymphomagenicity, by murine leukemia virus SL3-3 after mutation of a nuclear factor 1 site in the enhancerType B leukemogenic virus has a T-cell-specific enhancer that binds AML-1.Definition of a T-cell receptor beta gene core enhancer of V(D)J recombination by transgenic mapping.Auto-inhibition of Ets-1 is counteracted by DNA binding cooperativity with core-binding factor alpha2.RUNX3 regulates intercellular adhesion molecule 3 (ICAM-3) expression during macrophage differentiation and monocyte extravasation.Duplication of U3 sequences in the long terminal repeat of mink cell focus-inducing viruses generates redundancies of transcription factor binding sites important for the induction of thymomasThe corepressor mSin3A regulates phosphorylation-induced activation, intranuclear location, and stability of AML1.Increased lymphomagenicity and restored disease specificity of AML1 site (core) mutant SL3-3 murine leukemia virus by a second-site enhancer variant evolved in vivo.Genome-wide analyses reveal properties of redundant and specific promoter occupancy within the ETS gene familyRUNX1 and RUNX1-ETO: roles in hematopoiesis and leukemogenesis.Cell cycle and developmental control of hematopoiesis by Runx1.The feline leukemia virus long terminal repeat contains a potent genetic determinant of T-cell lymphomagenicityProviral insertions induce the expression of bone-specific isoforms of PEBP2alphaA (CBFA1): evidence for a new myc collaborating oncogeneCCAAT enhancer-binding protein (C/EBP) and AML1 (CBF alpha2) synergistically activate the macrophage colony-stimulating factor receptor promoter.Characterization of the cooperative function of inhibitory sequences in Ets-1.The extracellular signal-regulated kinase pathway phosphorylates AML1, an acute myeloid leukemia gene product, and potentially regulates its transactivation ability.Groucho-dependent and -independent repression activities of Runt domain proteinsSynergistic up-regulation of the myeloid-specific promoter for the macrophage colony-stimulating factor receptor by AML1 and the t(8;21) fusion protein may contribute to leukemogenesis.Runx-CBFbeta complexes control expression of the transcription factor Foxp3 in regulatory T cells.The antiproliferative ELF2 isoform, ELF2B, induces apoptosis in vitro and perturbs early lymphocytic development in vivoIdentification of a crucial site for synoviolin expression.Mutual activation of Ets-1 and AML1 DNA binding by direct interaction of their autoinhibitory domains.Transcriptional activation by ETS and leucine zipper-containing basic helix-loop-helix proteins.Suppressor mutations within the core binding factor (CBF/AML1) binding site of a T-cell lymphomagenic retrovirus.ETS-core binding factor: a common composite motif in antigen receptor gene enhancers.
P2860
Q22009417-8A531364-DA81-408E-AA92-1F3D4F9CDE9CQ24312874-1A70B71C-AA7D-466E-BC9A-7069A700C87CQ24314142-CD42457F-7628-4430-A500-56B91516D004Q24316983-AA28858A-C761-43BA-A373-DBD2E07EBA65Q24647133-F490AA37-73C7-4E50-873E-8D6030CE8558Q24672313-C5A9D09E-FA13-44AC-A1F8-DD29854C8811Q25257347-26F59C0C-9111-4139-9501-98F85B37B049Q27663883-9BF0D0EC-A5F8-4AFC-B77D-0D9C65907B63Q27678109-7384A696-0113-4E60-8550-B882F07C0490Q27682294-4D5F369A-847E-4667-8963-54B2A90ED306Q33519505-2C629B63-EA11-4AAC-B933-737E22132D24Q33648866-09979B78-9214-4BED-B513-B15AB948F7B9Q33774804-D2BEFA4D-4FE1-4587-83A2-74E6E65A8C08Q33781796-4020D154-F078-486A-BEF1-3C01377689F2Q33785027-91FB68B7-CA6A-45EA-859F-FD2194D9D342Q33825560-C95D557A-BEA6-441B-BEF4-5BA7003E85DFQ33850552-AEEB53C8-B78B-4FB1-9BB3-AA8EE78E73EFQ33961170-09D988EE-BFC2-4A15-9ACA-F1F731D4C5A9Q33961222-AF4FB3ED-A482-4FF4-AC73-F868293EBA0DQ34221376-D5B38FE3-9583-479E-B176-CA2300ECBC0FQ34757976-8C446480-1DAF-45AD-818E-19D25E289589Q35544219-923F6DEB-EA62-4306-9ADB-8E73D7F74B6BQ35894998-0744D8FC-E1BC-4091-980B-ECCBAF2C0B85Q35917053-5F8A7AA6-9B2F-46F3-8854-24F43F8A86CDQ36206674-32EE45A4-9C0F-448F-88C6-734E0504E382Q36543603-935FEE50-312D-470F-9BD4-2AF7FED43D86Q36549315-A2D8320D-436C-4CD5-BEBB-4B769E2CFDAAQ36552332-2A7CD039-9460-441F-B8F7-832AB40D5155Q36557608-3E3EE9B6-10D2-425D-A3D6-89644B05B945Q36559022-61CA1599-2FD6-4B8E-B3DA-C1686904B9F0Q36561099-AF098E64-58B5-49A5-AE0C-4CEED8AAC334Q36572515-6076B8FD-F42E-4ACB-9B73-D9635DA90CAAQ37273829-21956B82-1BA1-451D-8937-C827B4C79446Q37394198-EA39762F-AC00-4949-87B1-5D6C37D7C1EEQ37727031-E957DC13-6CBB-4D32-8E08-3674B7905542Q38322779-ABAA37C0-2CAF-499E-B583-F5B13E7130DFQ38327163-6E63188D-8915-4F3B-A98C-E5BD3D01415FQ39445279-2CF727A8-053A-4EC8-AF1F-4864D1819327Q39551832-E1AE7771-49A1-49CC-B3FA-DAEE522114F5Q39574510-27AFE726-F4D6-4E85-B603-095691496BDC
P2860
Transactivation of the Moloney murine leukemia virus and T-cell receptor beta-chain enhancers by cbf and ets requires intact binding sites for both proteins.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Transactivation of the Moloney ...... nding sites for both proteins.
@en
type
label
Transactivation of the Moloney ...... nding sites for both proteins.
@en
prefLabel
Transactivation of the Moloney ...... nding sites for both proteins.
@en
P2093
P2860
P1433
P1476
Transactivation of the Moloney ...... nding sites for both proteins.
@en
P2093
P2860
P304
P407
P577
1995-08-01T00:00:00Z